Senior Director, Commercial, EU Center
Bridgebio
Remote · Onsite · Full Time
Posted
Job description
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. What You’ll Do You will report to the VP & GM EU Center and work closely with Medical Affairs, Market Access, Patient Advocacy, Supply Chain and Finance, as well as global commercial teams, to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers. Your primary purpose will be to build and lead the commercial organisation in Germany, Austria and Switzerland, preparing and executing the launches in ADH1 and achondroplasia and building the foundation for future indications. You will lead the field force, including Disease Network Specialists who will move into Key Account Manager roles after launch, and drive the local adaptation of disease awareness and marketing materials, the local execution of customer service offerings, and forecasting and demand planning, with a focus on pre-launch readiness in 2027, followed by launch execution and growth. This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in rare disease commercial leadership and launch execution with strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment. Responsibilities Field force leadershi…